Valneva SE VALN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
8.90quote price arrow up+0.89 (+11.11%)
Volume
45,102
52 week range
6.58 - 17.05
Loading...
  • Open8.85
  • Day High8.88
  • Day Low8.10
  • Prev Close8.01
  • 52 Week High17.05
  • 52 Week High Date06/20/23
  • 52 Week Low6.58
  • 52 Week Low Date03/06/24

Key Stats

  • Market Cap504.43M
  • Shares Out139.15M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-14.65

KEY STATS

  • Open8.85
  • Day High8.88
  • Day Low8.10
  • Prev Close8.01
  • 52 Week High17.05
  • 52 Week High Date06/20/23
  • 52 Week Low6.58
  • 52 Week Low Date03/06/24
  • Market Cap504.43M
  • Shares Out139.15M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-14.65

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Valneva SE

 

Profile

MORE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli...
Anne-Marie Graffin
Independent Chairman of the Board
Thomas Lingelbach
President, Chief Executive Officer, Director
Vincent Dequenne
Chief Operating Officer
Peter Buehler
Chief Financial Officer
Frederic Jacotot
General Counsel, Corporate Secretary
Address
6 rue Alain Bombard
Saint-herblain
44800
France